Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04535271
Title Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
Acronym TAGGED
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.